ReconTop Stories

Exactech Announces Key Leadership Changes

March 30, 2022

Darin Johnson, Exactech President

GAINESVILLE, Fla.–(BUSINESS WIRE)–Exactech, a developer and producer of innovative implants, instrumentation, and smart technologies for joint replacement surgery, today announced it has formed a new leadership structure. Jeffrey R. Binder, Exactech’s Chairman of the Board, has been appointed Chief Executive Officer of the company. Darin Johnson will continue in the role of President. The changes, which are effective immediately, bring additional depth and expertise to Exactech’s executive leadership team to position the company for continued growth. Binder and Johnson will remain on Exactech’s board of directors.

Binder joined Exactech’s board in 2018. He is a 30-year veteran of the medical device and diagnostics industry, having served in several executive roles, including CEO of orthopaedic product developer Biomet and CEO of transfusion and transplantation diagnostics company Immucor. As CEO of Exactech, Binder will work closely with Johnson and the executive leadership team to drive overall business strategy and introduce new innovations in clinical care. In his capacity as President, Johnson will leverage his nearly 20 years of experience at Exactech to oversee the company’s business units, as well as its Human Resources and Information Technologies functions.

“Following the disruption caused by the COVID-19 pandemic, the orthopaedics market is on strong footing and ripe for solutions that help surgeons improve patients’ lives,” Binder said. “Today’s leadership changes will better position Exactech to address this demand. It’s a privilege to assume the role of CEO, and I’m excited to work with Darin and team, the board, and our partners at TPG to further Exactech’s market leadership.”

“Over the past several years, we have continued to strengthen our position as the innovation leader in shoulder while expanding our product and technology platforms through important product launches across our businesses,” Johnson said. “Throughout my nearly two decades at the company, I have seen this organization evolve, innovate, and grow, always in the pursuit of benefiting our employees and physician partners, as well as the patients we serve. I look forward to working with Jeff and the team to capitalize on the opportunities ahead.”

Exactech has recently launched several important new products. Earlier in March, Exactech announced the issuance of a patent for its Newton™ Knee, a dynamic platform of cutting-edge technology used with forward-thinking implants that are designed to provide optimal balance in a reproducible way. During last week’s American Academy of Orthopaedic Surgeons (AAOS) Annual Meeting, the company featured several new products, technologies and upcoming launches, including the Laser Cage Glenoid, Predict+ and Humeral Augmented Tray, as well as the Spartan Hip Stem, a next-generation, direct anterior hybrid stem.

About Exactech

Exactech is a global medical device company that develops and markets orthopaedic implant devices, related surgical instruments and the Active Intelligence® platform of smart technologies to hospitals and physicians. Headquartered in Gainesville, Fla., Exactech markets its products in the United States, in addition to more than 30 markets in Europe, Latin America, Asia and the Pacific. Visit for more information and connect with us on LinkedInVumediYouTubeInstagram and Twitter.

*Spartan Hip Stem is manufactured by Signature Orthopaedics and distributed by Exactech, Inc. Predict+ is developed by Blue Ortho, an Exactech subsidiary, and distributed by Exactech, Inc.

Nancy Walsh
Director, Marketing Communications

Chris J. Stewart

Chris currently serves as President and CEO of Surgio Health. Chris has close to 20 years of healthcare management experience, with an infinity to improve healthcare delivery through the development and implementation of innovative solutions that result in improved efficiencies, reduction of unnecessary financial & clinical variation, and help achieve better patient outcomes. Previously, Chris was assistant vice president and business unit leader for HPG/HCA. He has presented at numerous healthcare forums on topics that include disruptive innovation, physician engagement, shifting reimbursement models, cost per clinical episode and the future of supply chain delivery.

Related Articles

Back to top button